Denali Therapeutics Inc.
DNLINASDAQNASDAQ Global Select·USD·Closed
$21.74
+$0.15 (0.69%)
$21.74
+$0.15 (0.69%)
Not investment advice.Learn more
DNLI has more going for it than against it right now.
This company doesn't pay a dividend
A mid-sized company. Balances growth potential with stability
Continue with finqOS
SEC filings, earnings transcripts, insider trades, institutional ownership, 175+ screening metrics, and an infinite research canvas.
14-day free trial · No credit card required
52W Range
Near 52-week high
Volume
Market Cap
Mid-cap company
P/E Ratio
Div Yield
No dividend